In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantationPanagiotis Kottaridis, Stephen Mackinnon, Ruth Pettengell et al.|Blood|2000Cited by 502
Optimization of Chemotherapy for Younger Patients With Acute Myeloid Leukemia: Results of the Medical Research Council AML15 TrialAlan K. Burnett, Donald Milligan, Nigel H. Russell et al.|Journal of Clinical Oncology|2013Cited by 415
Attempts to Optimize Induction and Consolidation Treatment in Acute Myeloid Leukemia: Results of the MRC AML12 TrialAlan K. Burnett, Keith Wheatley, Robert K. Hills et al.|Journal of Clinical Oncology|2009Cited by 229
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With <i>NPM1</i> and <i>FLT3</i> MutationsNigel H. Russell, Shankara Paneesha, Charlotte S. Wilhelm-Benartzi et al.|Journal of Clinical Oncology|2024Cited by 40